Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Sevion Therapeutics Inc.
Fiscal year is July-June. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 140,000 0 200,000 0 100,000
Cost of Goods Sold (COGS) incl. D&A - 711,871 - - -
COGS excluding D&A - 568,597 - - -
Depreciation & Amortization Expense 126,567 143,274 258,023 293,629 349,656
Depreciation 2,548 2,798 - 2,583 18,275
Amortization of Intangibles 124,019 140,476 - 291,046 331,381
Gross Income - (711,871) - - -
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 4.2M 5.62M 5.03M 4.29M 6.67M
Research & Development 2.64M 3.72M 2.57M 1.91M 3.34M
Other SG&A 1.57M 1.9M 2.47M 2.38M 3.33M
Other Operating Expense 656,000 0 0 0 0
Unusual Expense (2.15M) 1.09M (151,326) 1.42M 2.23M
EBIT after Unusual Expense 2.15M (1.09M) 151,326 (1.42M) (2.23M)
Non Operating Income/Expense (135) 244,479 0 0 0
Non-Operating Interest Income 11,000 22,527 0 3,366 8,191
Equity in Affiliates (Pretax) 0 0 - 0 -
Interest Expense 10.7M 110,649 127,068 122,453 85,629
Gross Interest Expense 10.7M 110,649 127,068 122,453 85,629
Interest Capitalized 0 0 0 0 0
Pretax Income (13.38M) (7.27M) (5.07M) (6.12M) (9.23M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 - - -
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 - - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (13.38M) (7.27M) (5.07M) (6.12M) (9.23M)
Minority Interest Expense 0 0 0 0 0
Net Income (13.38M) (7.27M) (5.07M) (6.12M) (9.23M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (13.38M) (7.27M) (5.07M) (6.12M) (9.23M)
Preferred Dividends 6.24M 2.64M 1.63M 862,998 4.63M
Net Income Available to Common (19.62M) (9.91M) (6.69M) (6.99M) (13.85M)
EPS (Basic) (67.00) (14.00) (8.00) (5.00) (2.53)
Basic Shares Outstanding 291,130 693,325 857,033 1.37M 5.48M
EPS (Diluted) (67.00) (14.00) (8.00) (5.00) (2.53)
Diluted Shares Outstanding 291,130 693,325 857,033 1.37M 5.48M
EBITDA (4.72M) (6.19M) (4.83M) (4.29M) (6.57M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.